Submissions from 2017
Vena Cava Filter Retrieval Rates and Factors Associated with Retrieval in a Large US Cohort, Joshua D. Brown, Driss Raissi, Qiong Han, Val R. Adams, and Jeffery Talbert
Nephrotoxicity in Patients With or Without Cystic Fibrosis Treated With Polymyxin B Compared to Colistin, Ryan L. Crass, Wilbur Cliff Rutter, Donna R. Burgess, Craig A. Martin, and David S. Burgess
Quality of Life and Medication Adherence of Independently Living Older Adults Enrolled in a Pharmacist-Based Medication Management Program, Christopher Harlow, Catherine Hanna, Lynne Eckmann, Yevgeniya Gokun, Faika Zanjani, Karen Blumenschein, and Holly Divine
Optimizing Medication Appropriateness in Older Adults: A Randomized Clinical Interventional Trial to Decrease Anticholinergic Burden, Daniela C. Moga, Erin L. Abner, Dorinda N. Rigsby, Lynne Eckmann, Mark Huffmyer, Richard R. Murphy, Beth B. Coy, and Gregory A. Jicha
Bladder Antimuscarinics and Cognitive Decline in Elderly Patients, Daniela Claudia Moga, Erin L. Abner, Qishan Wu, and Gregory A. Jicha
An Investigation of Factors Predicting the Type of Bladder Antimuscarinics Initiated in Medicare Nursing Homes Residents, Daniela C. Moga, Qishan Wu, Pratik Doshi, and Amie J. Goodin
Medicaid Managed Care and the Health Care Utilization of Foster Children, Makayla Palmer, James Marton, Aaron Yelowitz, and Jeffery Talbert
Empirical Assessment of the Impact of Low-Cost Generic Programs on Adherence-Based Quality Measures, Nathan J. Pauly, Jeffery C. Talbert, and Joshua D. Brown
Nephrotoxicity During Vancomycin Therapy in Combination with Piperacillin-Tazobactam or Cefepime, Wilbur Cliff Rutter, Jessica N. Cox, Craig A. Martin, Donna R. Burgess, and David S. Burgess
Targeting the PD-1 Pathway in Pediatric Solid Tumors and Brain Tumors, Lars M. Wagner and Val R. Adams
Submissions from 2016
Incidence and Risk Factors of Thromboembolism with Multiple Myeloma in the Presence of Death as a Competing Risk: An Empirical Comparison of Statistical Methodologies, Joshua D. Brown and Val R. Adams
Impact of Time-Varying Treatment Exposures on the Risk of Venous Thromboembolism in Multiple Myeloma, Joshua D. Brown, Val R. Adams, and Daniela C. Moga
The Prevalence and Predictors of Low-Cost Generic Program Use in a Nationally Representative Uninsured Population, Joshua D. Brown, Nathan J. Pauly, and Jeffery C. Talbert
Use of Continuous Renal Replacement Therapy for Removal of Dabigatran in a Patient in Need of Emergent Surgery, Sara E. Parli, Melissa L. Thompson Bastin, and Daniel A. Lewis
National Trends in Off-Label Use of Atypical Antipsychotics in Children and Adolescents in the United States, Minji Sohn, Daniela C. Moga, Karen Blumenschein, and Jeffery Talbert
Inadequate Sedation During Therapeutic Paralysis: Use of Bispectral Index in Critically Ill Patients, Chelsea L. Tasaka, Jeremiah J. Duby, Komal Pandya, Machelle D. Wilson, and Kimberly A. Hardin
Submissions from 2015
Flucytosine Pharmacokinetics in a Critically Ill Patient Receiving Continuous Renal Replacement Therapy, Megan E. Kunka, Elizabeth A. Cady, Heejung C. Woo, and Melissa L. Thompson Bastin
A Coming Disruption in Pharmacy?, Frank Romanelli and Timothy S. Tracy
Utilizing Monte Carlo Simulations to Optimize Institutional Empiric Antipseudomonal Therapy, Sarah J. Tennant, Donna R. Burgess, Jeffrey M. Rybak, Craig A. Martin, and David S. Burgess
Prescription Drug Monitoring Program Utilization in Kentucky Community Pharmacies, Sarah E. Wixson, Karen Blumenschein, Amie J. Goodin, Jeffery Talbert, and Patricia R. Freeman
Azithromycin Drives Alternative Macrophage Activation and Improves Recovery and Tissue Sparing in Contusion Spinal Cord Injury, Bei Zhang, William M. Bailey, Timothy J. Kopper, Michael B. Orr, David J. Feola, and John C. Gensel
Submissions from 2014
Pharmacy Law Brief: Alternative Dispute Resolution, Joseph L. Fink III
Pharmacy Law Brief: Implications of Being a Specialist, Joseph L. Fink III
Pharmacy Law Brief: Medications and Lawful Executions, Joseph L. Fink III
Pharmacy Law Brief: The Federal False Claims Act, Joseph L. Fink III